Closing Remarks

The Multidisciplinary Association for Psychedelic Studies (MAPS) outlines its core mission to legalize psychedelic medicine while mobilizing community support to overcome critical funding hurdles. Major financial goals include sponsoring VA-affiliated studies, securing FDA approval for ibogaine, and funding phase 3 clinical trials for MDMA-assisted psychotherapy for PTSD in Europe.